A study of AZD5363 for advanced cancer

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

All cancer types




Phase 1

This study is looking at a new drug called AZD5363. It is for people who have a solid tumour Open a glossary item that has continued to grow despite all other standard treatments Open a glossary item.

More about this trial

Normally, cells in the body divide and grow in an organised way. But in cancer cells, some important proteins which help control cell growth start to behave abnormally. So the cells start to grow and divide more quickly.

In this study, researchers are looking at a drug called AZD5363 which has not been given to people before. Everyone in this study will have AZD5363.

There are now 4 parts to this study. Part A looked at how well the body copes with AZD5363, and how quickly it is absorbed into the bloodstream. People taking part had different doses at different times. Part B looked for the same things in a new group of people using the best dose level from part A.

The study is now running 2 extra parts called part C and part D. These will look at how well the body copes with the drug, and if there are any signs that the treatment is affecting the cancer in people with a change to genes called AKT1 or PIK3CA.

The main aims of the study are to

  • See how safe AZD5363 is
  • Find out about possible side effects
  • Learn how your cancer responds to the drug
  • Look at what AZD5363 does in the body

Who can enter

Please note that part A and part B are now closed. These parts recruited people with any solid tumour (apart from lymphoma Open a glossary item) that had got worse or come back despite having standard treatment Open a glossary item, or where there wasn't a standard treatment available.

You may be able to join part C if you have cancer of the ovary, cervix or womb, or breast cancer that is ER positive Open a glossary item or HER2 positive.

You may be able to join part D if you have one of the cancers listed above with a change to a gene called AKT1 - you can ask your doctor about this.

As well as the above

  • You have either had all the standard treatment you can, and your cancer has continued to grow or come back, or there is no standard treatment available
  • Your hospital has stored a sample of your cancer removed when you were diagnosed - you can check this with your doctor
  • Your cancer has not got worse in the last 2 weeks
  • You have satisfactory blood tests
  • You have at least one area of cancer that can be seen easily by doctors on a CT scan, MRI scan or X-ray, and the team will be able to monitor this through the study
  • You are well enough to carry out all your normal activities, apart from heavy physical work (performance status of 0 or 1)
  • You are willing to use 2 types of reliable contraception if there is any chance that you or your partner could become pregnant
  • You are at least 18 years old

You cannot enter this study if you

  • Have had any other anti cancer medication in the last 3 weeks
  • Have had treatment with nitrosourea chemotherapy Open a glossary item or mitomycin C in the last 6 weeks
  • Have taken any study drugs in another clinical trial in the last 30 days
  • Have taken certain medications that can affect body substances called CYP enzymes in the last 2 weeks, or 3 weeks if you have taken St John’s Wort (you can ask your doctor about this)
  • Have had radiotherapy to treat a large area in the last 4 weeks
  • Are still having side effects from previous cancer treatment (apart from hair loss)
  • Have spinal cord compression or cancer that has spread to your brain (if you do not have symptoms and have not needed steroids in the last 4 weeks you can still take part)
  • Have any condition that affects how your body uses sugar, for example diabetes Open a glossary item – you can check this with your doctor
  • Have low blood pressure that is uncontrolled (your readings are lower than 90 over 50)
  • Have any condition which would stop you being able to swallow or absorb the study medication
  • Have serious heart problems
  • Are allergic or sensitive to anything in AZD5363, or similar drugs
  • Have had major surgery in the last 4 weeks (if you had minor surgery to put in a central line or portacath, you can still take part)
  • Have hepatitis B, hepatitis C or HIV
  • Have any other condition that would make you unwell if you took part, or affect the results of the study - you can check this with your doctor
  • Are pregnant or breastfeeding
  • Have already been treated with AZD5363 in this study

Trial design

Everyone taking part will have AZD5363. It is a capsule that you take by mouth.

People in part C or part D of the study take AZD5363 twice a day for 4 days each week.

You should try to take your AZD5363 doses 12 hours apart. And not eat or drink anything except water for 2 hours before and 1 hour afterwards. But on the days you have a test to measure levels of AZD5363 in your blood, you should take the capsule to hospital with you and take it after your blood test. The team will ask you to record the study medication you take in a diary throughout the study.

You will have regular blood tests, urine tests and heart tests, and scans every 6 to 12 weeks. Your study doctor will give you more information about which tests you will have each time, and how long they will take.

For as long as you are taking AZD5363, you should avoid being in the sun too much, and using sun beds.

The team will ask if you would like to take part in some extra studies, which involve giving a sample of cancer tissue (a biopsy).

You would give a sample before you start treatment, and another after about 2 weeks of treatment, to see how AZD5363 may affect your cancer cells. If and when your cancer starts to get worse, the team would ask for another sample. They may look at this sample to measure what is happening, predict what will happen to the cancer, or to look at the side effects of AZD5363.

You do not have to take part in these extra studies if you don't want to. You can still take part in the main study.

You take the study medication for as long as the treatment is helping you and so long as you are coping with any side effects. If you need to stop taking the medication, you may still continue to see the study team - they will tell you long this would be for.

When you have finished taking part in the main study, your study doctor will discuss with you the next part of your treatment.

The team will contact you a month after you finish, and may phone you every 3 months to see how you are getting on.

Hospital visits

Before you join the study, you will see the doctor and have some tests. These tests include

  • Height, weight and blood pressure
  • Physical examination
  • CT scan or MRI scan
  • 3 heart traces (ECGs Open a glossary item)
  • Heart ultrasound (echo Open a glossary item) or a scan to show how well your heart is pumping blood around the body (MUGA scan Open a glossary item)
  • Blood and urine tests
  • Taking a sample of your cancer (if you are taking part in the tumour biopsy part of the study)

When you take your very first dose of AZD5363, you will have a number of tests including

  • Blood pressure
  • Physical examination
  • 3 ECGs (repeated 5 times)
  • Blood and urine tests (around 20 blood tests and 10 urine tests)
  • Taking a couple of small samples of hair from your eyebrows

At the start of the study, when you have a large number of blood tests, the doctor will put a small plastic needle into a vein in your arm, to take the blood from this. So you will not be pricked lots of times with a needle.

In this study, each 3 week period is called a cycle of treatment.   Everyone will visit the hospital on the first day of their first cycle of treatment. During the first cycle of treatment, you will need to test your urine for sugar twice a week. The team will show you how to do this. You will see the study team several times during the first cycle of treatment. The team will tell you more about this.

You then see the doctor on the first day of each following cycle of treatment, and have some blood and urine tests and one or more ECGs. You may have extra heart tests if your doctor thinks you need them.

Every 6 to 12 weeks you will also have a CT scan or MRI scan to record the size of your cancer.

When you finish the study, you will see the doctor and have more blood and urine tests and an ECG or MUGA scan. You will also have another CT scan or MRI scan.

If you decide to take part in the biopsy studies, you will give a sample of tissue when you start the study and again during the first cycle of treatment. And, once more if your cancers starts to get worse.

Side effects

AZD5363 is a new drug, but more than 90 people have already had the drug in this study. The side effects include

  • Changes to the levels of sugar, insulin and fat in your blood
  • Skin rash
  • Diarrhoea
  • Change to the strength of your heartbeat and blood pressure
  • Changes to your liver and how it works
  • Changes to some of the glands Open a glossary item that control hormone Open a glossary item levels in your body (thyroid Open a glossary item, pituitary Open a glossary item and adrenal glands Open a glossary item)
  • Changes to how your womb and ovaries Open a glossary item work (if you are a woman), or to your testicles Open a glossary item (if you are a man), which may affect your chance of having children

There may be some side effects the team do not know about. This is one of the reasons for the study. The team will follow you closely to check for side effects.

When you have your eyebrows plucked you may have pain, redness and rarely, infection.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Udai Banerji

Supported by

Experimental Cancer Medicine Centre (ECMC)

Freephone 0808 800 4040

Last review date

CRUK internal database number:


Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

Currently rated: 4.5 out of 5 based on 2 votes
Thank you!
We've recently made some changes to the site, tell us what you think